EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Association of Liver Fibrosis Markers with Mortality Outcomes in Patients with Chronic Kidney Disease and Coronary Artery Disease: Insights from the NHANES 1999–2018 Data

Zixiang Ye, Enmin Xie, Ziyu Guo, Yanxiang Gao, Zhongwei Han, Kefei Dou, Jingang Zheng

Cardiorenal Medicine · 21.01.2025 · 15 (1) · 153-163

DOI: 10.1159/000543500 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiorenal Medicine, online erschienen am 21.01.2025. Verfasst von Zixiang Ye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical C…. Hauptthemen laut MEDLINE: Coronary Artery Disease, Renal Insufficiency, Chronic, Liver Cirrhosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The objective of this research was to explore the possible link between markers of liver fibrosis and survival rates in a group of adults who have been diagnosed with both chronic kidney disease (CKD) and coronary artery disease (CAD).

Methods

The National Health and Nutrition Examination Survey (NHANES) data (1999–2018) for participants with both CAD and CKD were analyzed. The fibrosis-4 index (FIB-4), Nonalcoholic Fatty Liver Score (NFS), Forns index, and aspartate aminotransferase/alanine aminotransferase (AST/ALT) ratio were identified as crucial biomarkers. All-cause and cardiovascular disease (CVD) mortality were primary outcomes, assessed using Cox models, Kaplan-Meier curves, and receiver operating characteristic (ROC) analysis.

Results

A total of 1,192 CKD and CAD patients were included. The Cox regression analysis revealed substantial correlations between elevated FIB-4, NFS, Forns index, and AST/ALT levels and a heightened risk of all-cause (hazard ratio [HR]: 1.188, 95% confidence interval [CI]: 1.108–1.274; HR: 1.145, 95% CI: 1.069–1.227; HR: 1.142, 95% CI: 1.081–1.201; HR: 1.316, 95% CI: 1.056–1.639, respectively) and CVD mortality (HR: 1.133, 95% CI: 1.007–1.275; HR: 1.155, 95% CI: 1.024–1.303; HR: 1.208, 95% CI: 1.109–1.316 and HR: 1.636, 95% CI: 1.203–2.224, respectively). The ROC analysis indicated comparable predictive accuracy for all three biomarkers, with AST/ALT showing slightly superior performance.

Conclusion

Liver fibrosis markers, including AST/ALT, NFS, Forns index and FIB-4, are significant mortality predictors in CAD-CKD patients. The AST/ALT ratio, being easily measurable, may serve as an effective predictive tool for risk stratification in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseRenal Insufficiency, ChronicLiver CirrhosisHumansMaleFemaleBiomarkersMiddle AgedNutrition SurveysUnited StatesAspartate AminotransferasesAlanine TransaminaseAgedSurvival RateAdultRisk Factors

Stichwörter der Autor:innen

AST/ALT ratiosChronic kidney diseaseCoronary artery diseaseLiver fibrosis markersMortality

Substanzen

BiomarkersAspartate AminotransferasesAlanine Transaminase

Autor:innen und Institutionen

  • Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Cardiology, Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China.
  • Department of Cardiology, China-Japan Friendship Hospital, Beijing, China.
  • Department of Cardiology, Yantai Muping District Hospital of Traditional Chinese Medicine, Yantai, China.

Zitieren

APA

Ye, Z., Xie, E., Guo, Z., Gao, Y., Han, Z., Dou, K., & Zheng, J. (2025). Association of Liver Fibrosis Markers with Mortality Outcomes in Patients with Chronic Kidney Disease and Coronary Artery Disease: Insights from the NHANES 1999–2018 Data. Cardiorenal Medicine, 15(1), 153-163. https://doi.org/10.1159/000543500

Vancouver

Ye Z, Xie E, Guo Z, Gao Y, Han Z, Dou K, et al. Association of Liver Fibrosis Markers with Mortality Outcomes in Patients with Chronic Kidney Disease and Coronary Artery Disease: Insights from the NHANES 1999–2018 Data. Cardiorenal Medicine. 2025;15(1):153-163. doi:10.1159/000543500

BibTeX
@article{Ye2025,
  author = {Ye, Zixiang and Xie, Enmin and Guo, Ziyu and Gao, Yanxiang and Han, Zhongwei and Dou, Kefei and Zheng, Jingang},
  title = {Association of Liver Fibrosis Markers with Mortality Outcomes in Patients with Chronic Kidney Disease and Coronary Artery Disease: Insights from the NHANES 1999–2018 Data},
  journal = {Cardiorenal Medicine},
  year = {2025},
  volume = {15},
  number = {1},
  pages = {153--163},
  doi = {10.1159/000543500}
}
Kostenlos starten →